Amgen and Zai Lab's trial of gastric cancer therapy meets primary endpoint
The combo showed OS improvement against placebo with chemotherapy in G/GEJ patients with fibroblast growth factor receptor 2b (FGFR2b) overexpression, defined as 2+/3+ staining in at least 10% of tumour cells, as well as those who are non-human epidermal growth factor receptor 2 (HER2) positive.
The placebo-controlled, randomised, double-blind trial involved 547 subjects across 300 sites in 37 nations. It was designed to assess the combo as a first-line treatment for this patient group.
Its primary outcome measure is OS in those with FGFR2b ≥10% 2+/3+ tumour cell staining.
Key secondary outcome measures are overall response rate (ORR) and progression-free survival (PFS).
Notably, the trial incorporated more extensive ocular-related monitoring than earlier bemarituzumab trials.
Zai Lab, which holds joint development and commercialisation rights for the therapy in mainland China, Macau, Taiwan, and Hong Kong, supported the conduct of the FORTITUDE-101 trial.
Bemarituzumab has also received breakthrough therapy designation from the China Center for Drug Evaluation for treating FGFR2b-positive gastric and gastroesophageal junction adenocarcinoma.
In addition to FORTITUDE-101, a Phase III trial of bemarituzumab with chemotherapy and nivolumab is underway for the first-line gastric cancer treatment, with data readout expected in the second half of 2025.
Amgen research and development executive vice-president Jay Bradner said: "Most patients with gastric cancer are diagnosed at an advanced stage, with poor prognosis, low survival rates, and limited therapeutic options.
"These first positive top-line results of an FGFR2b targeted monoclonal antibody from our Phase III FORTITUDE-101 study mark a meaningful advance in the development of effective targeted therapy for gastric cancer."
"Amgen and Zai Lab's trial of gastric cancer therapy meets primary endpoint" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Myosin Therapeutics Awarded $4.5 Million NCI Bridge Grant to Advance Phase I Trial of MT-125 in Glioblastoma
JUPITER, Fla., Aug. 19, 2025 /PRNewswire/ -- Myosin Therapeutics, a biotechnology company developing novel therapies for aggressive cancers, today announced it has been awarded a $4.5M Phase IIB Bridge Award from the National Cancer Institute's (NCI) Small Business Innovation Research (SBIR) program. The funding will support Myosin Therapeutic's Phase I STAR-GBM dose escalation and expansion trial of MT-125, a first-in-class novel small molecule therapeutic being evaluated in patients with newly diagnosed, MGMT unmethylated glioblastoma. Glioblastoma remains among the most lethal cancers, with median survival measured in months. MT-125 targets non-muscle myosin II, a critical driver of tumor cell invasion, proliferation and treatment resistance, representing a novel therapeutic approach that is distinct from existing standards of care. The STAR-GBM trial will assess the safety, tolerability, and pharmacokinetics of MT-125 in this patient population with significant unmet need. Exploratory endpoints include measures of efficacy, including progression-free survival and overall survival. The NCI SBIR program is one of the most competitive federal funding mechanisms for cancer-focused innovation, providing support to small businesses with technologies that have strong scientific merit, commercial potential, and a clear path to clinical impact. Bridge Awards, which require that matching funds from private capital be raised first, are reserved for companies with promising, later-stage projects that have already demonstrated significant technical progress and the potential to attract substantial private investment. "The NCI Bridge Award was perfectly timed to support our STAR-GBM trial, for which patient enrollment is set to begin in November," said Dr. Courtney Miller, co-founder and CEO of Myosin Therapeutics. "It will enable us to generate the data needed to position the program for later-stage development, potential partnerships, and future expansion into a wider range of patients. Our ultimate goal is to deliver a transformative treatment option for patients who currently face limited or inadequate therapeutic choices." About Myosin TherapeuticsMyosin Therapeutics is a Jupiter, FL-based biotechnology company spun out of The Wertheim UF Scripps Institute (formerly Scripps Research, Florida). The company is focused on developing therapies for neuroscience and oncology indications using a platform that targets molecular nanomotor proteins. For more information, visit Contact: contact@ View original content to download multimedia: SOURCE Myosin Therapeutics Inc.
Yahoo
26 minutes ago
- Yahoo
ProLogium Leads the Way to Solid-State Battery Commercialization
TAIPEI, Taiwan, Aug. 20, 2025 (GLOBE NEWSWIRE) -- 'A battery that will not self-ignite, offers the world's highest conductivity, can be mass-produced, and is cost-competitive is no longer a castle in the air.' Against the backdrop of a global energy transition and rapidly evolving battery safety standards, solid-state battery technology has emerged as a focal point for the battery industry's future. ProLogium's recent launch of the world's first mass-producible GEN 4 solid-state lithium ceramic battery platform, marks a critical step from laboratory innovation to large-scale commercial deployment. At the heart of this breakthrough is ProLogium's proprietary SF-Ceramion Superfluidized All-Inorganic Solid-State Electrolyte, completing the final piece of the solid-state lithium ceramic battery puzzle. The innovation delivers a mass-production platform that unites scalability, manufacturability and cost competitiveness. This leap extends beyond electrolyte innovation to encompass cell architecture, manufacturing processes, and equipment systems— a holistic transformation that showcases ProLogium's integrated and systematic R&D capabilities. Leveraging years of technological expertise and a rich/deep global patent portfolio, ProLogium has established a GWh-scale demonstration plant in Taoyuan, Taiwan, with stable shipments already underway. Leveraging the expertise developed via that plant, ProLogium is moving ahead strongly towards the launch of its gigafactory in Dunkirk, France, to localize supply chains and scale up production. The GEN 4 platform achieves excellence in Safety × Performance × Cost × Mass Production, cementing ProLogium's role as a benchmark and a value-chain cornerstone for the next-generation battery industry. Founder & CEO Vincent Yang said: 'Delivery is just the beginning. We've built a replicable, scalable industrial framework for solid-state lithium batteries. The next step is to refine it and align precisely with global market needs. Together with partners, we will accelerate commercialization and advance the entire value chain to full maturity.' Architecture Definers: From Original Vision to Shared Industry PathAccording to global patent database analysis, ProLogium began securing core solid-state battery architecture patents as early as 2010. To date, it has amassed over 286 international patents spanning cell structures (including single-cell and bipolar designs), related manufacturing processes, and supporting equipment. These innovations showcase ProLogium's original technological prowess and establish a solid foundation for licensing, strategic alliances, and industry expansion. In cell architecture design, ProLogium was the first to introduce multiple breakthrough concepts that defined the 'industry-standard blueprint' for next-generation solid-state lithium batteries. In recent years, several international battery startups and automakers have unveiled stacking and packaging structures strikingly similar to ProLogium's designs—evidence that this technical approach has become/established? an industry-wide consensus and a testament to the feasibility and foresight of ProLogium's early innovations. As the saying goes, 'great minds think alike.' Today, this shared design logic is becoming the common language of the global solid-state battery sector, further cementing ProLogium's leadership in cell structure design and process Since 2010, ProLogium has been building a global patent moat around core solid-state lithium battery technologies, covering single-cell and bipolar structures, ceramic separators, and the integration of manufacturing processes and equipment. The timeline shows how ProLogium's early patent directions have now become design paths now followed by major international players, validating both foresight and mass-production Since 2017, ProLogium has expanded its patent coverage for bipolar cells (BiPolar+) and ceramic separator architectures, including structural designs, manufacturing methods, and system integration. Multiple global automakers have filed similar patents in recent years, further validating the foresight of ProLogium's design approach and its emergence as a mainstream industry direction. Facing the barriers to mass production of solid-state batteries, ProLogium has taken the lead in completing full-chain technology integration—from materials and cell architecture to processes and equipment. ProLogium has also advanced an open collaboration model, partnering with upstream and downstream partners to build a scalable and standardized industry value chain. While most companies remain cautious about the feasibility of mass production, ProLogium's forward-looking, systematic deployment has already opened an important chapter in the commercialization of the solid-state battery. From Trials to Mass Production: High Yields Prove Solid-State Battery ScalabilityWhere battery technology viability depends not only on lab results but also on stable, high-throughput, and consistent manufacturing performance, ProLogium has built a proven track record. Since building its first 0.01 GWh sample line in 2013, ProLogium has upheld the belief that 'from concept to reality—every innovation must deliver,' continuously accumulating production know-how. From sheet-based to more manufacturing-efficient roll-based cells, ProLogium has developed EV-grade solid-state batteries with all-ceramic separators, increasing capacity from 10 Ah to 170 Ah. Since 2016, these batteries have been supplied to major European and Asian automakers for testing. In 2017, the company established the world's first pilot line for roll-to-roll all-ceramic separator solid-state batteries (250–330 mm width) and between 2018 and 2019, completed the world's first on-road EV tests with WM Motor and Enovate, becoming one of the earliest in the industry to achieve mass-production-grade applications. In 2023, ProLogium completed the world's first 660 mm-wide, GWh-scale roll-to-roll solid-state battery production line—an important milestone in scalable manufacturing. By Q3 2024, the line had stably shipped over 500,000 solid-state lithium ceramic cells, proving its yield control and large-scale production stability. ProLogium also stands as the only company worldwide with both solid-state cells and modules certified for safety and electrical performance by TÜV, a leading independent testing body. The Core Behind the Production: Innovative Materials Redefine the Manufacturing Universe'Batteries are chemical engineering, not digital chips. Change the formula, and you must rebuild the entire manufacturing universe.' As Vincent Yang emphasizes, ProLogium develops materials not merely to make batteries, but to create manufacturing processes that integrate seamlessly into production lines. Since 2010, ProLogium has been securing foundational patents for single-cell and bipolar module designs, laying the groundwork for industry standardization. In 2017, the company achieved a >90% yield rate on its automated pilot line, showcasing deep expertise in system integration and process control. ProLogium's Taoyuan demonstration plant has become a focal point for site visits from policymakers and industry partners worldwide reinforcing its role as a model for global solid-state battery mass production and a catalyst for industry-wide progress. In 2024, ProLogium became the first company to publicly release a full video of a GWh-scale solid-state lithium ceramic battery production line, offering the industry an unprecedented, end-to-end manufacturing reference. The video showcases each critical stage—from target-aligned printing and wet ceramic separator coating, to frame adhesive printing, cathode-anode alignment and lamination, inlay stacking without polymer separators, and pouch packaging without liquid electrolyte filling. This open demonstration not only validates the maturity and scalability of ProLogium's technology but also provides the industry with a clear, systematic manufacturing frameworkCaption: ProLogium's self-developed GWh-scale next-generation solid-state lithium ceramic battery production line integrates high-speed roll-to-roll ceramic coating (30–50 m/min), rotary adhesive coating (15–30 m/min), high-temperature/high-pressure lamination, and the world's first modular Inlay unit design, achieving 0.1 sec/layer stacking and eliminating liquid electrolyte filling. This simplifies processes, boosts yields, and enhances safety. In 2024, revenue reached USD 5.3 million, up 134% year-on-year, validating both technical strength and global growth potential. Cost advantage: Breaking the High-Cost Myth of Solid-State BatteriesCost has long been seen as the final hurdle to large-scale commercialization of solid-state batteries. Despite their exceptional safety and electrochemical performance, all-inorganic solid-state batteries have been held back by expensive materials and complex processes, reinforcing the industry's perception that they are too costly to scale. ProLogium's GEN 4 Superfluidized All-Inorganic Solid-State Electrolyte (SF Ceramion) breaks through this barrier with multiple innovations in material design and process integration. Compared to sulfide-based solid electrolytes, SF Ceramion significantly simplifies electrode fabrication, reduces dry room requirements, and enhances overall production scalability, unlocking a clear path to cost-competitive mass production. Material costs for ProLogium's SF Ceramion are only 3–5% of those for conventional sulfide systems, with the future potential to match the cost of liquid electrolytes. This is not just a theoretical improvement, but a result validated through engineering design and verified on a demonstration production line. By combining material innovation with manufacturing-friendly processes, ProLogium has redefined the cost structure of the full production system for solid-state batteries, delivering a scalable, feasible, and economically viable commercialization pathway. This electrolyte breakthrough, together with ProLogium's decade-long progress in cell architecture and manufacturing platforms, enhances the integration, yield control, and production scalability of its GEN 4 solid-state lithium ceramic battery. It unlocks the cross-sector application potential across automotive, energy storage, defense, and aerospace applications. Leading is Not About Being Different, It's About Showing the World the Way ForwardFrom material invention and process design to patent strategy, equipment integration, mass production, and stable delivery, ProLogium has spent nearly two decades building a truly scalable battery future. Today, as more global battery makers adopt manufacturing paths and structural designs pioneered by ProLogium, this 'technological resonance' underscores the feasibility and foresight of its early innovations, solidifying its leadership in cell architecture, process integration, and equipment engineering. The manufacturing capabilities demonstrated by the GEN 4 platform not only position ProLogium for global expansion but also create tangible value to end markets. Looking ahead, ProLogium will continue to work with industry partners and policymakers worldwide to accelerate the energy transition toward a safer, more efficient, and more sustainable low-carbon future. About ProLogium TechnologyFounded in 2006, ProLogium Technology is an energy innovation company dedicated to the R&D and manufacturing of next-generation lithium ceramic batteries. Its proprietary technologies are protected by over a thousand global patents (granted and pending). After introducing the world's first next-gen battery with 100% ceramic separators in 2013, ProLogium has been at the forefront of the battery technology. In 2025, ProLogium once again leads the industry by launching the world's first Superfluidized all Inorganic Solid-State Lithium Battery. ProLogium's Gigafactory in Taoyuan, Taiwan came online in 2024 and has shipped more than 500,000 battery cells to date. This steady supply to the global market is a testimony of its technology readiness and mass production capability. In May 2024, the company inaugurated its first overseas R&D center in Paris-Saclay, France, to provide tailored technological solutions for the European market. Its first overseas Gigafactory project, located in Dunkirk, France, successfully completed both environmental and construction permitting processes by the end of 2024. Construction is scheduled to begin in 2026, with mass production of fourth-generation batteries starting in 2028, ramping up to 4 GWh capacity by 2029, and full production by 2030. Press Contacts:Sam Chang, ProLogium TechnologyTel: 03-452-1991#18802E-mail: sam@ Sara Lin, ProLogium TechnologyTel: 03-452-1991#1880 6E-mail: sara@ Photos accompanying this announcement are available at: A video accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Fast Company
27 minutes ago
- Fast Company
Black beauty businesses are stuggling under Trump's tariffs
Earlier this summer, Dajiah Blackshear-Calloway, 34, started to notice that her regular clients weren't visiting her hair salon as often as they used to. The salon, in Smyrna, Georgia, houses two stylists and offers dozens of services that range from $50 natural hairstyles to $745 tape-in weave extensions. Her most popular services are $254 sew-ins, where human hair extensions are woven into braids, and $125 quick weaves, where human or synthetic hair is styled and then glued to a stocking cap. But the prices of hair extensions and hair glues used to create wigs and weaves have gone up exponentially after U.S. President Donald Trump imposed a series of different tariffs on China and Vietnam, where the majority of Black beauty products are made. The price of a package of hair imported from Vietnam has gone up to $290 from $190 since May. A bottle of hair glue, imported from China, has gone up from $8 a bottle to $14.99 at her local beauty supply store. 'We're being impacted at every level,' Blackshear-Calloway said. 'I'm either having to eat that cost or pass that expense along to my clients, which affects their budgets and their pockets as well.' To avoid passing on rising costs, Blackshear-Calloway is asking her clients to bring their own hair to their appointments. Now her salon is offering a quick weave service without hair for $140, but with hair the price is $400, according to her booking website. She's also struggling to get products since her wholesaler is delaying shipments as tariff rates fluctuate. Kadidja Dosso, 30, owner of Dosso Beauty, which sells hypoallergenic braiding hair, as well as The Dosso Hair Salon in Philadelphia, has also faced delayed shipments on imports from China. She waited over a month to get $50,000 worth of China-made braiding hair via air freight at John F. Kennedy Airport in June, when U.S. President Donald Trump announced 145% tariffs on the country over confusion over what tariff should apply. 'We have to provide more specifics of the products – exact materials, the product use – for it to clear customs,' Dosso said. 'Part of the issue was that the same language that we've been using for years wasn't descriptive enough.' She wants to avoid raising prices on her $13 packets of hair, which customers typically buy at least five at a time to complete one hairstyle. Higher costs Tariffs are disproportionately impacting Black business owners like Blackshear-Calloway and Dosso, said Andre Perry, senior fellow at the Brookings Institution. 'Many Black entrepreneurs started off with less wealth,' Perry said. He said that the wealth gap puts Black entrepreneurs, especially those in low-margin businesses like consumer goods or hair care services, into precarious financial positions as tariffs eat into their bottom lines. Sina Golara, an assistant professor of supply chain and operations management at Georgia State University, said rising costs due to tariffs are 'like a tax that you're imposing on business.' 'In some cases, it could be borne by the foreign manufacturer, but in most cases, it will also have quite a substantial impact on the domestic buyers and consumers,' Golara said. Diann Valentine, 55, founder of Slayyy Hair, first felt the impact of tariffs shortly after the initial 145% tariff was imposed on China and she faced a $300,000 bill to get 26,000 units of braiding hair out of the Los Angeles port in May. 'To lose that kind of money at this stage has been devastating,' Valentine said. Since then she has raised the price of her braiding hair and drawstring ponytail extensions by 20%. She also laid off four employees and is working 16-hour days to compensate in her two Glow+Flow beauty supply stores in Inglewood and Hawthorne, California. Slayyy Hair supplies $8.49 nontoxic braiding hair and $35.99 synthetic drawstring ponytails to TJ Maxx and Marshalls, which have resisted renegotiating prices or delivery deadlines to compensate. 'So essentially, we paid more for our ponytails than TJ Maxx and Marshalls paid for them,' Valentine said. She is also trying to renegotiate price increases with Target, where she sells in at least 70 stores in California, Nevada and Colorado, she said. TJ Maxx and Marshalls declined a Reuters request for comment. Fifty percent of the merchandise comes from China, Valentine said, and prices for synthetic wigs, human-hair weaves, plastic hair rollers, rubber bands, combs and brushes that stock her shelves are trending up at her beauty supply locations. 'I thought maybe we would see an increase in foot traffic because there would be more DIY hairstyles – more women doing their hair at home,' she said. 'But for right now, we've only seen decreased foot traffic and also a decrease in frequency of visits from our existing customers.' Struggling salons While beauty product sales are typically resilient during economic downturns, beauty services are seen as discretionary, said Marley Brocker, senior analyst at market research firm IBISWorld. 'Tariffs on those imports are going to directly lead to higher costs for those service providers, whether they're buying directly from overseas manufacturers or buying from wholesalers within the U.S.,' she said. Black U.S. consumers spent approximately $2.29 billion on hair care products in 2022, according to a NielsenIQ study from that year. But higher prices are causing some Black women to visit the salon less frequently. Deiara Frye, 27, of Raleigh, North Carolina, usually schedules hair appointments at least five times a year, but so far this year she's only gone once. 'Due to the cost of everything rising over the years, I tend to get braids a little more often now than sew-ins, or try to maintain my natural hair,' she said. She's also seeing prices for her natural hair products like Unilever's Shea Moisture and Procter & Gamble's Pantene go up. Fewer visits are impacting salons and beauty supply stores. Until earlier this year, Dionne Maxwell was selling wigs, braiding hair, shampoos, and conditioners out of her mini beauty supply store in Dallas, Georgia, located 33 miles outside of Atlanta, but she shut it down after she started losing foot traffic in May and moved operations into her home. Now she's relying on orders placed through Uber Eats, TikTok Shop and to sustain her business, but even those sales have slowed significantly, she said. 'We don't have the money for advertising, because enough revenue is not coming in to advertise with,' Maxwell said. Tariffs have raised Maxwell's wholesale price for China-made braiding hair by 50 cents per pack, she said, and she is now required to buy more hair in her wholesale orders. She said she's struggled to negotiate better prices with her hair wholesalers, who are requiring her to order more units of merchandise at higher costs. Her wholesaler is asking her to purchase 110 packs of hair per order, when she was previously able to buy 30 packs at a time, she said. 'For the past two months, we have been basically paying our bills out of pocket because we really have had nothing coming in,' Maxwell said.
